DT&CRO Co (XKRX:383930) Receivables Turnover : 2.31 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. DT&CRO Co's Revenue for the three months ended in Mar. 2024 was ₩6,579 Mil. DT&CRO Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩2,847 Mil. Hence, DT&CRO Co's Receivables Turnover for the three months ended in Mar. 2024 was 2.31.

DT&CRO Co Receivables Turnover Historical Data

The historical data trend for DT&CRO Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Receivables Turnover Chart

DT&CRO Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

5.04

9.84

14.36

8.55

DT&CRO Co Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial					3.48	3.57	2.57	0.27	2.31

Competitive Comparison of DT&CRO Co's Receivables Turnover

For the Biotechnology subindustry, DT&CRO Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DT&CRO Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DT&CRO Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where DT&CRO Co's Receivables Turnover falls into.

DT&CRO Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

DT&CRO Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	26586.277	/ (	(3461.512	+	2756.161)	/	2 )
=	26586.277	/	3108.8365
=	8.55

DT&CRO Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	6579.29	/ (	(2756.161	+	2937.17)	/	2 )
=	6579.29	/	2846.6655
=	2.31

DT&CRO Co (XKRX:383930) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

DT&CRO Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

DT&CRO Co (XKRX:383930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042

Website

http://www.dtncro.com

DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines